🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Heart Failure Congenital

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC NCT06228924Phase 17 sites📍 San Francisco📍 Aurora📍 Baltimore Tenaya Therapeutics · Tests: TN-401 Cardiac Amyloidosis Registry of University Hospital Leipzig NCT06129656n/a1 site📍 Leipzig University of Leipzig · Tests: Routine diagnostics, Routine treatment REHAB Fontan Failure: A Trial of Cardiac Rehabilitation NCT06150950NA2 sites📍 Stanford📍 Nashville Stanford University · Tests: Cardiac rehabilitation, Usual care The Danish TURNER Cryopreservation Study NCT05740579NA1 site📍 Aarhus University of Aarhus · Tests: laparoscopic cryopreservation of one ovary the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients NCT07692256Phase 21 site📍 Cairo Ain Shams University · Tests: Empagliflozin (EMPA), Standard medical treatment Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging NCT03581318n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy NCT06634108Phase 1, Phase 21 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Genistein The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R) NCT04848844n/a1 site📍 Hamburg Universitätsklinikum Hamburg-Eppendorf Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children NCT01604395n/a1 site📍 Seoul LG Chem Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia NCT06597019Phase 366 sites📍 San Francisco📍 San Francisco📍 Washington D.C. Novartis Pharmaceuticals · Tests: Inclisiran, Placebo Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study) NCT07347197Phase 1, Phase 25 sites📍 Tsukuba📍 Kawasaki📍 Matsumoto Heartseed Inc. · Tests: HS-005 Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation NCT06813443n/a3 sites📍 Bologna📍 Roma📍 Florence IRCCS Azienda Ospedaliero-Universitaria di Bologna Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD NCT03593317Phase 213 sites📍 Amiens📍 Bron📍 Clermont-Ferrand Hospices Civils de Lyon · Tests: Spironolactone, Placebo Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy NCT07172971Phase 11 site📍 Nashville Vanderbilt University Medical Center · Tests: SGLT-2 inhibitor, SGLT2 inhibitor Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer NCT06713993n/a1 site📍 Budapest Semmelweis University Wearable Technology to Evaluate Hyperglycemia and HRV in DMD NCT06124196n/a1 site📍 Nashville Vanderbilt University Medical Center · Tests: wearable technology SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure NCT06955260Phase 32 sites📍 Vancouver📍 Toronto Subodh Verma · Tests: Empagliflozin 10 mg, Placebo Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections NCT06056297Phase 3114 sites📍 Phoenix📍 Irvine📍 La Jolla X4 Pharmaceuticals · Tests: Mavorixafor, Placebo Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT) NCT06688396NA1 site📍 Lancaster Lancaster General Hospital · Tests: Mobile 6L AI-EKG Screening Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) NCT04278404n/a52 sites📍 Phoenix📍 Little Rock📍 Los Angeles Duke University · Tests: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the fol… MedlyPeds Feasibility Study NCT07556185NA1 site📍 Toronto The Hospital for Sick Children · Tests: MedlyPeds App RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases NCT07491237n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: speckle tracking echocardiography US Benchmarking Clinical Study NCT07215715n/a3 sites📍 Boston📍 Boston📍 Boston eMyosound SAS Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging NCT05081115n/a1 site📍 Benevento Fatebenefratelli Hospital · Tests: ABCDE-Stress Echo, SE diastolic assessment, SE Right ventricular function assessment, SE in heart donors Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy NCT05564689n/a1 site📍 Aalborg Ashkan Eftekhari · Tests: Intracoronary flow and pressure Cardiovascular Multimodality Imaging Study NCT06610019n/a1 site📍 The Bronx Montefiore Medical Center Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System NCT06080074Phase 25 sites📍 Palo Alto📍 New York📍 Durham Stanford University · Tests: Cardiohelp device (VA-ECMO), Heparin, Bivalirudin Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure. NCT07029230n/a1 site📍 Zurich Martin Schweiger
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy